The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - MSD; Takeda
Research Funding - Takeda; Varian Medical Systems
Travel, Accommodations, Expenses - Merck Serono; Takeda
Randomised phase II study with cetuximab in combination with 5-FU and cisplatin or carboplatin versus cetuximab in combination with paclitaxel and carboplatin for treatment of patients with relapsed or metastatic squamous cell carcinoma of the head and neck (CETMET trial).
 
Signe Friesland
No Relationships to Disclose
 
Georgios Tsakonas
No Relationships to Disclose
 
Claus Kristensen
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD
 
Maria Herlestam Calero Moren
No Relationships to Disclose
 
Hedda Haugen
No Relationships to Disclose
 
Karin Soderstrom
No Relationships to Disclose
 
Lena Specht
No Relationships to Disclose